Skip to main content
. 2010 Jun 22;468(11):3047–3055. doi: 10.1007/s11999-010-1430-5

Fig. 2.

Fig. 2

Lifetime table analysis of the treatment survival in the two groups. The end point is the failure of the procedure. The treatment was considered failed when a fracture occurred or when there was no response to treatment after 6 months or in the presence of recurrence of the cyst with the need for subsequent treatment (Neer IV). The DBM + BMC Group showed fewer failures compared to the Steroid Group (Wilcoxon-Gehan test; p = 0.001).